HBK Investments »

Humacyte shares owned by HBK Investments

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by HBK Investments from 13F filings

Historical chart of HBK Investments investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by HBK Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by HBK Investments

Quarter filed Position value Share count Share price at filing
2026-06-30 $617k 790k 0.78

More positions owned by HBK Investments

Topbuild
Electronic Arts (EA)
Penumbra (PEN)
Norfolk Southern (NSC)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Kenvue (KVUE)
Warner Bros Discovery Com Ser A (WBD)
Bio-techne Corporation (TECH)
Nuvalent Inc-a (NUVL)
Apogee Therapeutics (APGE)
Chart Industries (GTLS)
Teck Resources CL B (TECK)
Janus Henderson Group Ord Shs
Gamestop Corp Note 6/1 (Principal)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for HBK Investments

Top funds holding Humacyte

Vanguard Capital Management
Antipodes Partners
Alyeska Investment Group
Davidson Kempner Capital Management
BlackRock
Dr. Jeffrey R. Jay, M.D.
State Street Corporation
Susquehanna International
UBS Group
AQR Capital Management
Geode Capital Management
Millennium Management
Citadel Advisors
Charles Schwab Investment Management
Sixth Street Partners Management Company

View all funds holding Humacyte